Literature DB >> 11900520

From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs.

Anne Robert1, Odile Dechy-Cabaret, Jérôme Cazelles, Bernard Meunier.   

Abstract

In the first part of this account, the antimalarial drug artemisinin is presented, and the current hypotheses on the mechanism of action of this endoperoxide-based drug are reviewed. The alkylating ability of artemisinin and synthetic analogues toward heme related to their antimalarial efficacy are underlined. Some possible ways for discovery of new drugs, especially the design of trioxaquines, new active molecules recently patented that have been prepared by covalent attachment of a trioxane residue having alkylating ability to a quinoline moiety known to easily penetrate within infected erythrocytes, are presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900520     DOI: 10.1021/ar990164o

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  31 in total

1.  The antimalarial drug artemisinin alkylates heme in infected mice.

Authors:  Anne Robert; Françoise Benoit-Vical; Catherine Claparols; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

2.  Endoperoxide synthesis by photocatalytic aerobic [2 + 2 + 2] cycloadditions.

Authors:  Jonathan D Parrish; Michael A Ischay; Zhan Lu; Song Guo; Noël R Peters; Tehshik P Yoon
Journal:  Org Lett       Date:  2012-02-28       Impact factor: 6.005

3.  Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.

Authors:  Françoise Benoit-Vical; Joël Lelièvre; Antoine Berry; Caroline Deymier; Odile Dechy-Cabaret; Jérôme Cazelles; Christophe Loup; Anne Robert; Jean-François Magnaval; Bernard Meunier
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

Review 4.  Plasmodium drug targets outside the genetic control of the parasite.

Authors:  David J Sullivan
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.

Authors:  Sunny Manohar; U Chinna Rajesh; Shabana I Khan; Babu L Tekwani; Diwan S Rawat
Journal:  ACS Med Chem Lett       Date:  2012-06-10       Impact factor: 4.345

6.  Artemisinin-naphthoquine combination: A directly observed treatment option in malaria.

Authors:  M S Mustafa; V Rastogi
Journal:  Med J Armed Forces India       Date:  2016-03-29

7.  Trioxaquine PA1259 alkylates heme in the blood-feeding parasite Schistosoma mansoni.

Authors:  Vincent Pradines; Julien Portela; Jérôme Boissier; Frédéric Coslédan; Bernard Meunier; Anne Robert
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

8.  Selection of a trioxaquine as an antimalarial drug candidate.

Authors:  Frédéric Coslédan; Laurent Fraisse; Alain Pellet; François Guillou; Benjamin Mordmüller; Peter G Kremsner; Alicia Moreno; Dominique Mazier; Jean-Pierre Maffrand; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

9.  Synthesis of spiroannulated and 3-arylated 1,2,4-trioxanes from mesitylol and methyl 4-hydroxytiglate by photooxygenation and peroxyacetalization.

Authors:  Axel G Griesbeck; Lars-Oliver Höinck; Jörg M Neudörfl
Journal:  Beilstein J Org Chem       Date:  2010-06-07       Impact factor: 2.883

10.  Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.

Authors:  Fernando de Pilla Varotti; Ana Cristina C Botelho; Anderson Assunção Andrade; Renata C de Paula; Elaine M S Fagundes; Alessandra Valverde; Lúcia M U Mayer; Jorge Souza Mendonça; Marcus V N de Souza; Núbia Boechat; Antoniana Ursine Krettli
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.